IDH2 and chondrosarcoma: IDH1 and IDH2 mutated chondrosarcomas have a distinct metabolomic profile with increased lactate, the TCA intermediates succinate, fumarate, and malate, amino acids broadly and acylcarnitines compared to non-mutated cancer cells based on patient derived xenografts (21).